For example, RARα was shown to be associated with tomoxifen resistant in breast cancer9 and RXRα was essential for the oncogenic activity of promyelocytic leukemia (PML) fused with RARα (PML/RARα) in driving leukemia progression in vivo10. This evidence concerns the gene RARA and leukemia.